Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake.
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake.
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.
US firm Eli Lilly, which is also pushing for end to rebate scheme, optimistic about talks with ministers The US pharmaceutical group behind the Mounjaro weight-loss drug has said it will unpause its UK investments if…
McCormick will pay a combination of cash and equity to expand further into condiments and spreads.
Core focus will be on beauty, personal care and home products after spinning off brands such as Hellmann’s and Pot Noodle into $60bn entity Business live – latest updates Unilever is in advanced talks to combine its…
The tie-up between Unilever and McCormick highlights a shift in strategy among consumer goods companies that prioritizes dominating specific categories